KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.83 $2.63 Friday, 26th Apr 2024 CGEN stock ended at $1.92. This is 1.05% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.74% from a day low at $1.86 to a day high of $1.98.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
Apr 12, 2016 $6.24 $6.47 $6.21 $6.41 148 215
Apr 11, 2016 $6.18 $6.40 $6.18 $6.24 83 013
Apr 08, 2016 $6.28 $6.30 $6.17 $6.21 52 250
Apr 07, 2016 $6.07 $6.29 $6.04 $6.18 100 894
Apr 06, 2016 $5.69 $6.14 $5.69 $6.13 308 225
Apr 05, 2016 $5.60 $5.70 $5.52 $5.64 70 670
Apr 04, 2016 $5.67 $5.74 $5.61 $5.66 111 685
Apr 01, 2016 $5.55 $5.69 $5.47 $5.66 92 152
Mar 31, 2016 $5.68 $5.76 $5.54 $5.58 94 440
Mar 30, 2016 $5.60 $5.72 $5.59 $5.69 106 748
Mar 29, 2016 $5.50 $5.60 $5.31 $5.59 211 700
Mar 28, 2016 $5.82 $5.82 $5.54 $5.57 79 200
Mar 24, 2016 $5.80 $5.94 $5.59 $5.82 60 800
Mar 23, 2016 $5.90 $5.95 $5.65 $5.72 72 400
Mar 22, 2016 $5.75 $5.99 $5.75 $5.93 77 600
Mar 21, 2016 $5.51 $5.83 $5.51 $5.80 109 500
Mar 18, 2016 $5.41 $5.68 $5.41 $5.59 214 000
Mar 17, 2016 $5.36 $5.54 $5.33 $5.46 68 100
Mar 16, 2016 $5.34 $5.39 $5.25 $5.35 81 800
Mar 15, 2016 $5.50 $5.50 $5.25 $5.34 205 700
Mar 14, 2016 $5.51 $5.60 $5.46 $5.53 53 700
Mar 11, 2016 $5.42 $5.65 $5.42 $5.59 118 400
Mar 10, 2016 $5.57 $5.57 $5.30 $5.33 55 600
Mar 09, 2016 $5.56 $5.59 $5.36 $5.45 88 500
Mar 08, 2016 $5.86 $5.86 $5.50 $5.50 111 500
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT